Daily Archives: January 8, 2019

HR Thought Leader Josh Bersin Joins Virgin Pulse CEO Advisory Board

PROVIDENCE, R.I., Jan. 08, 2019 (GLOBE NEWSWIRE) — Virgin Pulse, the largest global employee health and wellbeing company, today announced that renowned HR technology analyst and influencer Josh Bersin, has joined Virgin Pulse’s CEO Advisory Board. In this capacity, Bersin will

DoubleVerify Partners with MoPub to Combat Mobile Ad Fraud

Partnership extends DV fraud coverage across MoPub’s mobile app exchange NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) — DoubleVerify (“DV”), the leading independent provider of marketing measurement software and analytics, today announced a partnership with MoPub, a leading provider of

Quantenna’s Spartan Architecture Brings High-Capacity Mesh Wi-Fi to TIME’s Malaysian Customers

LAS VEGAS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Quantenna Communications, Inc. (NASDAQ : QTNA) announced today that Quantenna’s QV860 chipset is powering TIME dotCom’s latest dual-band dual concurrent mesh extender, the WiFi Booster. Based on the AirTies Air 4830, the

Infovista names José Duarte as Chief Executive Officer

Newly appointed CEO to strengthen position for next stage of growth and scale PARIS and ASHBURN, Va., Jan. 08, 2019 (GLOBE NEWSWIRE) — Infovista, the leader in modern network performance, today announced that its Board of Directors has appointed José

LeddarTech Joins Baidu’s Apollo Autonomous Driving Open Platform

LeddarTech joins Baidu’s Apollo autonomous driving open platform with its LiDAR products through an open source SDK QUEBEC CITY, Jan. 08, 2019 (GLOBE NEWSWIRE) — LeddarTech, an industry leader providing the most versatile and scalable auto and mobility LiDAR platform,

Lupin Limited: Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders Zug, Switzerland, 8 January 2019: Lupin is pleased to announce that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types – head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers – involving around 340 patients Most of

Individual quit-rent for stratified properties next year Khalid

KUALA LUMPUR, Jan 8 (Bernama) -- The Federal Territories Ministry will be implementing the individual lot quit-rent system to replace quit-rent on individual building for stratified properties from 2020.Its Minister, Khalid Abd Samad said it is a tax o...

37 companies have not paid RM3 million sponsorship money to Istana Budaya

KUALA LUMPUR, Jan 8 (Bernama) -- As many as 37 companies who were sponsors for shows in Istana Budaya owe it RM3 million since 2010, Tourism, Arts and Culture Minister Datuk Mohamaddin Ketapi.From this year, he said, Istana Budaya will

Two men claim trial to unlawful possession of alcoholic beverages

PETALING JAYA, Jan 8 (Bernama) -- Two men pleaded not guilty in the Magistrate's Court here today to unlawful possession of contraband alcoholic beverages.M. Harikrishnan, 31, and H. Prabakaran, 26, entered the plea when the charges were read out separ...